These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2575146)

  • 21. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
    Starr MS; Starr BS
    Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A; Kulkarni SK
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.
    Johansen PA; Clarkl D; White FJ
    Life Sci; 1988; 43(6):515-24. PubMed ID: 2900459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
    Meltzer LT; Wiley JN; Williams AE; Heffner TG
    Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.
    Jackson DM; Hashizume M
    J Neural Transm; 1987; 69(1-2):131-45. PubMed ID: 2953861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
    Matsumoto S; Yamada K; Nagashima M; Domae M; Shirakawa K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):21-5. PubMed ID: 2571944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
    Barone P; Davis TA; Braun AR; Chase TN
    Eur J Pharmacol; 1986 Apr; 123(1):109-14. PubMed ID: 2872071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
    Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A; Kulkarni SK; Nayar U
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
    Jackson DM; Ross SB; Larsson LG
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1987 Aug; 39(8):660-1. PubMed ID: 2888862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
    Andén NE; Grabowska-Andén M
    J Neural Transm Gen Sect; 1990; 79(3):209-14. PubMed ID: 2136999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
    Zarrindast MR; Shahed-Dirin K
    Psychopharmacology (Berl); 1990; 100(2):275-80. PubMed ID: 2305016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM; Hashizume M
    Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.